Federal Register - February 4, 2021
Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.
Fuente: Federal Register
8220
Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices
Authority: Section 2 of the Paperwork Reduction Act of 1995, 44 U.S.C. 3507.
Colette Pollard, Department Management Reports Management Officer, Office of the Chief Information Officer.
Controlled substance
Drug code
Schedule
To submit comments:
Send them to:
Remifentanil
9739
II
By mail
Assistant Attorney General, U.S. DOJENRD, P.O.
Box 7611, Washington, D.C. 200447611.
The company plans to import the above-controlled substance as the Federal Drug Administration-approved drug product in finished dosage form for commercial distribution to its customers. Approval of permit applications will occur only when the registrants business activity is consistent with what is authorized under 21 U.S.C. 952a2.
FR Doc. 202102256 Filed 2321; 8:45 am BILLING CODE 421067P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Docket No. DEA773
DEPARTMENT OF JUSTICE
During the public comment period, the proposed consent decree may be examined and downloaded at this Justice Department website: https
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the proposed consent decree upon written request and payment of reproduction costs. Please mail your request and payment to: Consent Decree Library, U.S. DOJENRD, P.O. Box 7611, Washington, DC 200447611.
Please enclose a check or money order for $8.50 25 cents per page reproduction cost payable to the United States Treasury.
Notice of Lodging of Proposed Consent Decree Under the Clean Air Act CAA
Jeffrey Sands, Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division.
William T. McDermott, Assistant Administrator.
Importer of Controlled Substances Application: Mylan Pharmaceuticals Inc.
FR Doc. 202102315 Filed 2321; 8:45 am BILLING CODE P
Drug Enforcement Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Mylan Pharmaceuticals Inc.
has applied to be registered as an importer of basic classes of controlled substances. Refer to Supplemental Information listed below for further drug information.
SUMMARY:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 8, 2021. Such persons may also file a written request for a hearing on the application on or before March 8, 2021.
DATES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: 1 Drug Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and 2 Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
ADDRESSES:
In accordance with 21 CFR 1301.34a, this is notice that on December 18, 2020, Mylan Pharmaceuticals Inc., 2898
Manufacturers Road, Greensboro, North Carolina 274064600, applied to be registered as an importer of the following basic classes of controlled substances:
jbell on DSKJLSW7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:13 Feb 03, 2021
Jkt 253001
On January 29, 2021, the Department of Justice lodged a proposed consent decree with the United States District Court for the District of Utah in the lawsuit entitled United States v.
Stericycle, Inc., Civil Action No. 1:21
cv00012JNP.
The United States filed this lawsuit under the Clean Air Act alleging violations of NOx emission limits at Stericycle, Inc.s medical waste incinerator in North Salt Lake, Utah an ozone nonattainment area and other related violations. The proposed consent decree will require Stericycle to pay a $600,000 civil penalty and conduct a supplemental environmental project to replace 1520 pre-2006 diesel school buses with low emitting models at an estimated cost of $2,000,000.
The publication of this notice opens a period for public comment on the proposed consent decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and should refer to United States v. Stericycle, Inc., D.J. Ref. No. 9052112057. All comments must be submitted no later than thirty 30 days after the publication date of this notice.
Comments may be submitted either by email or by mail:
To submit comments:
Send them to:
By email
pubcomment-ees.enrd@
usdoj.gov.
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
FR Doc. 202102353 Filed 2321; 8:45 am BILLING CODE 441015P
DEPARTMENT OF LABOR
Agency Information Collection Activities; Submission for OMB
Review; Comment Request; Alternative Method of Compliance for Certain Simplified Employee Pensions Notice of availability; request for comments.
ACTION:
The Department of Labor DOL is submitting this EBSAsponsored information collection request ICR to the Office of Management and Budget OMB for review and approval in accordance with the Paperwork Reduction Act of 1995
PRA. Public comments on the ICR are invited.
DATES: The OMB will consider all written comments that agency receives on or before March 8, 2021.
ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/
PRAMain. Find this particular information collection by selecting Currently under 30-day ReviewOpen for Public Comments or by using the search function.
Comments are invited on: 1 Whether the collection of information is necessary for the proper performance of the functions of the Department, SUMMARY:
E:FRFM04FEN1.SGM
04FEN1